Robins M, Chiang T, Mores K, Alongkronrusmee D, van Rijn R. Critical Role for Gi/o-Protein Activity in the Dorsal Striatum in the Reduction of Voluntary Alcohol Intake in C57Bl/6 Mice. Front Psychiatry. 2018;9:112 pubmed publisher

Wang D, Tawfik V, Corder G, Low S, Francois A, Basbaum A, et al. Functional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain Circuits. Neuron. 2018;98:90-108.e5 pubmed publisher

Ye Y, Bernabé D, Salvo E, Viet C, Ono K, Dolan J, et al. Alterations in opioid inhibition cause widespread nociception but do not affect anxiety-like behavior in oral cancer mice. Neuroscience. 2017;363:50-61 pubmed publisher

Levoye A, Zwier J, Jaracz Ros A, Klipfel L, Cottet M, Maurel D, et al. A Broad G Protein-Coupled Receptor Internalization Assay that Combines SNAP-Tag Labeling, Diffusion-Enhanced Resonance Energy Transfer, and a Highly Emissive Terbium Cryptate. Front Endocrinol (Lausanne). 2015;6:167 pubmed publisher

Neumann C, Bigliardi Qi M, Widmann C, Bigliardi P. The δ-opioid receptor affects epidermal homeostasis via ERK-dependent inhibition of transcription factor POU2F3. J Invest Dermatol. 2015;135:471-480 pubmed publisher

Schuster D, Metcalf M, Kitto K, Messing R, Fairbanks C, Wilcox G. Ligand requirements for involvement of PKC? in synergistic analgesic interactions between spinal ? and ? opioid receptors. Br J Pharmacol. 2015;172:642-53 pubmed publisher

Ong E, Xue L, Olmstead M, Cahill C. Prolonged morphine treatment alters ? opioid receptor post-internalization trafficking. Br J Pharmacol. 2015;172:615-29 pubmed publisher

Erbs E, Faget L, Scherrer G, Matifas A, Filliol D, Vonesch J, et al. A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks. Brain Struct Funct. 2015;220:677-702 pubmed publisher

Pradhan A, Smith M, Zyuzin J, Charles A. δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice. Br J Pharmacol. 2014;171:2375-84 pubmed publisher

Milan Lobo L, Enquist J, van Rijn R, Whistler J. Anti-analgesic effect of the mu/delta opioid receptor heteromer revealed by ligand-biased antagonism. PLoS ONE. 2013;8:e58362 pubmed publisher

Burbassi S, Sengupta R, Meucci O. Alterations of CXCR4 function in ?-opioid receptor-deficient glia. Eur J Neurosci. 2010;32:1278-88 pubmed publisher

Butelman E, Rus S, Prisinzano T, Kreek M. The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects. Psychopharmacology (Berl). 2010;210:253-62 pubmed publisher

Pacheco D, Klein A, Perez A, Pacheco C, de Francischi J, Reis G, et al. Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor. Br J Pharmacol. 2009;158:225-31 pubmed publisher

Markkanen P, Petäjä Repo U. N-glycan-mediated quality control in the endoplasmic reticulum is required for the expression of correctly folded delta-opioid receptors at the cell surface. J Biol Chem. 2008;283:29086-98 pubmed publisher

da Fonseca Pacheco D, Klein A, de Castro Perez A, da Fonseca Pacheco C, de Francischi J, Duarte I. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors. Br J Pharmacol. 2008;154:1143-9 pubmed publisher

Scherrer G, Tryoen Toth P, Filliol D, Matifas A, Laustriat D, Cao Y, et al. Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc Natl Acad Sci U S A. 2006;103:9691-6 pubmed

Sluka K, Rohlwing J, Bussey R, Eikenberry S, Wilken J. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists. J Pharmacol Exp Ther. 2002;302:1146-50 pubmed

Gomes I, Jordan B, Gupta A, Trapaidze N, Nagy V, Devi L. Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. J Neurosci. 2000;20:RC110 pubmed